Display Settings:

Format

Send to:

Choose Destination
Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Myeloid Leukaemia: A Systematic Review and Economic Evaluation.

Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Myeloid Leukaemia: A Systematic Review and Economic Evaluation.

Rogers G, Hoyle M, Thompson Coon J, et al.

Southampton (UK): NIHR Journals Library; 2012 Apr. (Health Technology Assessment, No. 16.22.)

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk